| |
In vitro
|
|---|
| |
Beta
|
Peak point
|
Cut-off point
|
Branching parameter
|
|---|
|
Seizure-like activity
|
−10.032 ± 0.379
|
22.8 ± 1.584
|
19.8 ± 5.954
|
1.317 ± 0.022
|
|
High bic (50 μM)
|
−8.6152 ± 0.837
|
44.2 ± 4.732*
|
34.5 ± 7.445*
|
1.322 ± 0.035
|
|
Oct (100 μM)
|
−9.710 ± 0.729
|
11.2 ± 1.018*
|
11.5 ± 2.339*
|
1.297 ± 0.041
|
|
Thalamic cut-off
|
−13.22 ± 0.053*
|
13.4 ± 0.456*
|
61.4 ± 5.341*
|
1.358 ± 0.020
|
| |
In vivo
|
| |
Beta
|
Peak point
|
Cut-off point
|
Branching parameter
|
|
Spontaneous
|
−9.112 ± 0.512
|
21.9 ± 3.401
|
32.4 ± 1.147
|
1.221 ± 0.072
|
|
Seizure-like activity
|
−10.015 ± 0.692
|
24.8 ± 2.921
|
32.7 ± 1.098
|
1.329 ± 0.061
|
|
Thalamic lesion
|
−10.862 ± 0.462
|
26.3 ± 1.866
|
33 ± 0.912
|
1.365 ± 0.095
|
- The data are expressed as mean ± standard error. *p < 0.01.
